.FDA declines psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Permit MDMA Therapy, Seeking Additional Study The Nyc TimesFDA Refuses Ecstasy-Based Drug The Exchange JournalFDA declines to authorize unfamiliar MDMA treatment to handle PTSD, along with ask for even more hearing information CNNFDA turns down initially psychedelic to treat post-traumatic stress disorder, asking for additional research study The Washington Article.